NgospelMedia.Net
NgospelMedia.net is The No. 1 International Largest Repository of Your Favourite Gospel Entertainment Website, WorldWide, Nigeria. We Published Latest Naija Gospel Music Downloads, Videos; Lyrics, Artiste Biography, Daily Devotionals. NgospelMedia is mainly a Christian Website, as the Domain Name Speaks; Gospel; Which is also tagged as a Gospel On-line Ministry for Souls Winning...

COVID-19: Nigeria to continue Chloroquine trial despite WHO’s warning

0

- Advertisement -









The National Agency for Food and Drug Administration and Control (NAFDAC) has insisted it will continue Chloroquine clinical trials for COVID-19 treatment, despite the suspension of the drug test by the World Health Organisation (WHO).

NAFDAC director-general, Mojisola Adeyeye, stated this while speaking on TVC on Tuesday.

Adeyeye said there is data to prove that Chloroquine is effective in treating Coronavirus patients, particularly at the “mild stage” of infection.

She said Nigeria would continue its clinical trials which may take three to four months.

“There is data to prove that hydroxychloroquine worked for many COVID-19 patients. Therefore, we would continue our own clinical trials in Nigeria. Hydroxychloroquine has been proved to work at a mild stage. So the potency depends on the severity of the disease in the patient’s body.



“If medical doctors, research scientists, pharmacists, herbal experts work together, we should conclude the clinical trial in three to four months. The narrative might change afterward but for now, we believe in hydroxychloroquine,” Adeyeye said.

Read More:  NERC: Nigerian govt re-appoints dispute resolution panel members

On Monday, the WHO suspended its solidarity trial on the use of hydroxychloroquine for treatment of COVID-19 patients.

The WHO Director-General, Tedros Ghebreyesus, explained that the trials had been “suspended while the safety is reviewed.”

- Advertisement -

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

- Advertisement -

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More